Your browser is no longer supported. Please, upgrade your browser.
Settings
NVET Nexvet Biopharma Public Limited Company daily Stock Chart
NVET [NASD]
Nexvet Biopharma Public Limited Company
Index- P/E- EPS (ttm)-1.75 Insider Own0.60% Shs Outstand11.93M Perf Week0.30%
Market Cap79.22M Forward P/E- EPS next Y-1.70 Insider Trans0.00% Shs Float9.51M Perf Month0.45%
Income-20.50M PEG- EPS next Q-0.38 Inst Own61.40% Short Float0.22% Perf Quarter104.94%
Sales- P/S- EPS this Y26.10% Inst Trans-0.54% Short Ratio0.29 Perf Half Y66.83%
Book/sh1.78 P/B3.73 EPS next Y5.00% ROA-63.80% Target Price6.72 Perf Year128.18%
Cash/sh1.22 P/C5.46 EPS next 5Y- ROE-72.70% 52W Range2.75 - 6.76 Perf YTD77.99%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-1.72% Beta-
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin- 52W Low141.45% ATR0.02
Employees28 Current Ratio5.30 Sales Q/Q- Oper. Margin- RSI (14)84.96 Volatility0.20% 0.23%
OptionableNo Debt/Eq0.00 EPS Q/Q-2.80% Profit Margin- Rel Volume0.21 Prev Close6.63
ShortableYes LT Debt/Eq0.00 EarningsMay 11 Payout- Avg Volume71.35K Price6.64
Recom3.00 SMA200.32% SMA5019.61% SMA20051.03% Volume15,124 Change0.11%
Apr-24-17Downgrade Credit Suisse Outperform → Neutral
Feb-04-16Initiated Credit Suisse Outperform
May-11-17 08:52PM  Nexvet Biopharma plc ("Nexvet") Rule 2.10 Announcement GlobeNewswire
05:30AM  Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2017 GlobeNewswire
Apr-17-17 09:40AM  Zoetis (ZTS) Inks Agreement to Acquire Nexvet Biopharma Zacks
Apr-13-17 09:02PM  Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion Animals Business Wire +63.46%
09:24AM  Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion Animals Business Wire
Mar-13-17 06:07AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Mar-10-17 04:40PM  AbbVie Outperforms Drug Stocks On $20.5 Billion Growth View Investor's Business Daily +11.60%
04:40PM  AbbVie Outperforms Drug Stocks On $20.5 Billion Growth View
Feb-22-17 05:30AM  Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-16-17 01:04PM  NEXVET BIOPHARMA PLC Financials
Feb-10-17 07:07AM  Q2 2017 Nexvet Biopharma plc Earnings Release - Time Not Supplied +6.62%
06:12AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
05:30AM  Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017 GlobeNewswire
Dec-12-16 05:30AM  Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats GlobeNewswire
Dec-06-16 10:13AM  Nexvet Biopharma PLC :NVET-US: Earnings Analysis: Q1, 2017 By the Numbers : December 6, 2016 +5.79%
Nov-18-16 06:04AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission
Nov-04-16 09:37AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
07:07AM  Q1 2017 Nexvet Biopharma plc Earnings Release - Time Not Supplied
06:11AM  NEXVET BIOPHARMA PLC Files SEC form 10-Q, Quarterly Report
05:30AM  Nexvet Reports Financial Results for First Quarter of Fiscal Year 2017 GlobeNewswire
Oct-19-16 05:30AM  Nexvet to Present at the 25th Annual Credit Suisse Healthcare Conference GlobeNewswire
Oct-04-16 06:55AM  Zomedica Appoints Two Animal Health Veterans to Board of Directors GlobeNewswire
Sep-02-16 09:38AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi -10.67%
07:07AM  Q4 2016 Nexvet Biopharma plc Earnings Release - Time Not Supplied
06:07AM  NEXVET BIOPHARMA PLC Files SEC form 10-K, Annual Report
05:30AM  Nexvet Biopharma Reports Full Year Fiscal 2016 Results GlobeNewswire
Jul-20-16 05:30AM  Nexvet Announces Publication of Two Peer-Reviewed Journal Articles Profiling Frunevetmab (NV-02) and Presentation at the Veterinary Pain Short Course Conference GlobeNewswire
Jun-10-16 05:02PM  Nexvet Biopharma PLC :NVET-US: Earnings Analysis: Q3, 2016 By the Numbers : June 10, 2016 Capital Cube -6.16%
05:02PM  Nexvet Biopharma PLC :NVET-US: Earnings Analysis: Q3, 2016 By the Numbers : June 10, 2016
08:25AM  Nexvet Biopharma (NVET) Jumps: Stock Moves 9.2% Higher Zacks
Jun-09-16 07:32AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +9.23%
05:30AM  Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM GlobeNewswire
Jun-03-16 06:10AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +10.53%
05:30AM  Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement GlobeNewswire
May-27-16 05:30AM  Nexvet Provides Update on Upcoming Investor Symposium at Irish Biomanufacturing Facility GlobeNewswire +7.94%
May-26-16 06:09AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
05:30AM  Nexvet Announces Positive Results from NV-02 Pilot Field Study in Cats with Osteoarthritis GlobeNewswire
May-12-16 09:38AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
07:07AM  Q3 2016 Nexvet Biopharma plc Earnings Release - Time Not Supplied
06:13AM  NEXVET BIOPHARMA PLC Files SEC form 10-Q, Quarterly Report
05:30AM  Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2016 GlobeNewswire
May-11-16 05:30AM  Nexvet to Host Symposium at American College of Veterinary Internal Medicine (ACVIM) Forum to Present Additional NV-01 Pivotal Data in Canine Pain and Clinical Data for NV-02 in Feline Pain GlobeNewswire -5.12%
May-04-16 05:30AM  Nexvet to Host Investor Symposium at its Irish Biomanufacturing Facility GlobeNewswire
May-02-16 05:30AM  Nexvet and Zenoaq Announce PD-1 mAb Candidate for Canine Cancer GlobeNewswire
Mar-08-16 06:20AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
05:30AM  Nexvet Announces Successful Completion of NV-01 Pilot Field Study in Dogs With Osteoarthritis GlobeNewswire
Mar-02-16 10:46AM  5 Stocks Insiders Have Been Scooping Up Lately at TheStreet
Feb-29-16 05:30AM  Nexvet to Present at the Cowen and Company 36th Annual Health Care Conference GlobeNewswire
Feb-16-16 06:27AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
06:17AM  NEXVET BIOPHARMA PLC Files SEC form 10-Q, Quarterly Report
05:30AM  Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2016 GlobeNewswire
Feb-04-16 01:15PM  Credit Suisse Identifies 5 Stocks to Buy Winning From Your Pets Health at 24/7 Wall St. +11.18%
07:42AM  Coverage initiated on Nexvet Biopharma by Credit Suisse
Jan-14-16 06:48AM  5 Stocks Under $10 Set to Soar at TheStreet +5.11%
Dec-29-15 03:20PM  Bill & Melinda Gates Foundation Trusts Latest Bet on China & Two Other Latest Hedge Fund Moves at Insider Monkey
Dec-08-15 05:30AM  Nexvet to Discuss Pivotal Study Success of Lead Program and Product Pipeline at Bank of America Merrill Lynch 2015 Animal Health Summit GlobeNewswire
Nov-24-15 05:30AM  Nexvet to Present at the 27th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Nov-23-15 09:08AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +8.51%
06:00AM  Nexvet Biopharma plc (Nasdaq: NVET) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Nov-20-15 04:31PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission
Nov-16-15 04:06PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -15.37%
05:30AM  Nexvet Announces Positive Results From NV-01 Pivotal Study in Dogs With Osteoarthritis GlobeNewswire
Nov-14-15 04:55PM  Nexvet Hosting Teleconference to Provide Update on NV-01 Pivotal Study GlobeNewswire
Nov-12-15 05:30AM  Nexvet Provides Speaker Update for Animal Health Symposium in New York City GlobeNewswire
Nov-05-15 04:09PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi +6.26%
07:35AM  NEXVET BIOPHARMA PLC Files SEC form 10-Q, Quarterly Report
06:00AM  Nexvet Reports Financial Results for First Quarter of Fiscal Year 2016 GlobeNewswire
Oct-29-15 03:12PM  AMAG to Initiate Head-to-Head Phase III Study on Feraheme +6.36%
Oct-21-15 09:15AM  Illumina Tops Q3 Earnings, Meets Revenues; '15 View Cut
Oct-19-15 05:30AM  Nexvet Initiates Pilot Field Study of NV-02 for Feline Osteoarthritis Pain GlobeNewswire
Oct-16-15 09:00AM  CMS Hikes Medicare Rate for Genomic's Breast Cancer Test (Revised)
Oct-14-15 03:50PM  Incyte & Merck Expand Melanoma Treatment Collaboration
Oct-13-15 06:30PM  BioMarin Presents Data on Vosoritide at Medical Meeting
Oct-09-15 02:00PM  Alnylam Initiates Extension Study on ALN-AT3 for Hemophilia
Oct-06-15 05:30AM  Nexvet to Host Animal Health Symposium in New York City GlobeNewswire
Oct-05-15 03:49PM  Hedge Funds Expect Big Things From 1 Of These 2 Sliding Biotechs at Insider Monkey
Oct-02-15 04:15PM  Sanofi Opts into Alnylam's ALN-AT3 Hemophilia Program +5.15%
04:10PM  BioMarin (BMRN) to Acquire Rights to Phenylketonuria Drugs
10:53AM  Nexvet Biopharma PLC Earnings Q4, 2015
Sep-29-15 05:30AM  Nexvet Receives FY2015 Cash Refund of $3.2 Million GlobeNewswire
Sep-28-15 02:00PM  Genomic Health Posts Positive Breast Cancer Trial Results
Sep-21-15 01:30PM  Neogenomics Hits a 52-Week High on Cancer-Testing Deal -6.08%
Sep-17-15 06:03AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Sep-16-15 05:30AM  Nexvet Secures Biomanufacturing Facility and Receives IDA Ireland Support GlobeNewswire
Sep-03-15 05:15PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:15PM  Nexvet Biopharma Reports Full Year Fiscal 2015 Results GlobeNewswire
Aug-11-15 01:48PM  4 Biotech Stocks Under $10 to Trade for Breakouts at TheStreet
Jul-23-15 11:49AM  5 Health Care Stocks Under $10 Set to Soar at TheStreet
Jul-07-15 05:30AM  Nexvet and Zenoaq Enter Research and Development Collaboration GlobeNewswire
Jul-02-15 05:31PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
Jun-10-15 05:30AM  Nexvet to Present at the JMP Securities Life Sciences Conference 2015 GlobeNewswire
Jun-08-15 09:32AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:30AM  Nexvet Advances Manufacturing Strategy GlobeNewswire
Jun-04-15 08:25AM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits +11.93%
05:30AM  Nexvet Announces Positive Top-Line Results for Proof-of-Concept Efficacy Study of NV-02 in Cats With Degenerative Joint Disease GlobeNewswire
May-11-15 04:03PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
05:30AM  Nexvet Appoints Dr. Jurgen Horn as Chief Product Development Officer GlobeNewswire
May-08-15 04:04PM  NEXVET BIOPHARMA PLC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:26AM  NEXVET BIOPHARMA PLC Files SEC form 10-Q, Quarterly Report
05:30AM  Nexvet Reports Financial Results for Third Quarter of Fiscal Year 2015 GlobeNewswire
Nexvet Biopharma public limited company, a clinical-stage biopharmaceutical company, focuses on developing and commercializing species-specific biologics. Its product candidates include Ranevetmab, a monoclonal antibody (mAb) that targets and inhibits the function of nerve growth factor (NGF) for the control of pain associated with osteoarthritis in dogs; and Frunevetmab, a mAb that targets NGF inhibitor for the control of pain associated with degenerative joint disease, including osteoarthritis in cats. The company is also developing NV-03, a mAb targeting NGF that is being evaluated as a therapy for chronic joint pain in horses. In addition, it has research and development collaboration with Zenoaq for applying PETization technology to convert mAb candidates into species-specific candidates in the areas of immuno-oncology, inflammation, and allergy. Nexvet Biopharma public limited company is headquartered in Tullamore, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PATEL RAJIV AMember of Group Owning 10%Mar 31Option Exercise0.13500639,480Apr 03 02:03 PM
McCracken Joseph SDirectorMar 31Option Exercise0.135006312,300Apr 04 11:23 AM
Hanna AshrafDirectorMar 31Option Exercise0.135006311,920Apr 04 11:20 AM
Gunn George WDirectorMar 31Option Exercise0.135006338,500Apr 04 11:16 AM
McCracken Joseph SDirectorDec 31Option Exercise0.135006311,800Jan 03 07:38 PM
Hanna AshrafDirectorDec 31Option Exercise0.135006311,420Jan 03 07:34 PM
Gunn George WDirectorDec 31Option Exercise0.135006338,000Jan 03 07:29 PM
PATEL RAJIV AMember of Group Owning 10%Dec 31Option Exercise0.13500638,980Jan 04 10:57 AM
McCracken Joseph SDirectorSep 30Option Exercise0.135006311,300Oct 04 03:52 PM
Hanna AshrafDirectorSep 30Option Exercise0.135006310,920Oct 04 03:47 PM
Gunn George WDirectorSep 30Option Exercise0.135006337,500Oct 04 03:44 PM
PATEL RAJIV AMember of Group Owning 10%Sep 30Option Exercise0.13500638,480Oct 04 09:26 AM